FTRE Fortrea Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FTRE

Price (delayed)

$17.27

Market cap

$1.63B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.84

Enterprise value

$2.6B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 22

Fortrea is a leading global contract research organization (CRO) helping customers bring life-changing solutions to patients faster. With over 19,000 professionals conducting operations in more than 90 countries, Fortrea is ...

Highlights
The net income has soared by 55% from the previous quarter and by 43% YoY
The EPS has soared by 55% from the previous quarter and by 45% YoY
The gross margin has contracted by 6% YoY but it has grown by 2.2% from the previous quarter
FTRE's equity is down by 39% YoY and by 7% QoQ
Fortrea Holdings's gross profit has decreased by 6% YoY
Sector: Healthcare
Industry: Biotechnology
Website: https://www.fortrea.com
Peers: GILD VRTX REGN BIIB

Key stats

What are the main financial stats of FTRE

FTRE stock price

How has the Fortrea Holdings stock price performed over time
Intraday
10.49%
1 week
15.13%
1 month
40.98%
1 year
230.21%
YTD
0.12%
QTD
83.33%

Financial performance

How have Fortrea Holdings's revenue and profit performed over time
Revenue
$2.71B
Gross profit
$510.9M
Operating income
-$355.9M
Net income
-$446.9M
Gross margin
18.9%
Net margin
-16.5%
Fortrea Holdings's operating income has soared by 59% from the previous quarter and by 45% YoY
Fortrea Holdings's operating margin has soared by 59% from the previous quarter and by 45% YoY
The net income has soared by 55% from the previous quarter and by 43% YoY
The net margin has surged by 54% since the previous quarter and by 44% year-on-year

Price vs fundamentals

How does FTRE's price correlate with its fundamentals

Growth

What is Fortrea Holdings's growth rate over time

Valuation

What is Fortrea Holdings stock price valuation
P/E
N/A
P/B
3.07
P/S
0.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.96
The EPS has soared by 55% from the previous quarter and by 45% YoY
The price to book (P/B) is 74% higher than the last 4 quarters average of 1.6
FTRE's equity is down by 39% YoY and by 7% QoQ
FTRE's P/S is 80% above its last 4 quarters average of 0.3

Efficiency

How efficient is Fortrea Holdings business performance
The ROS has soared by 59% from the previous quarter and by 47% YoY
The return on invested capital has surged by 58% since the previous quarter and by 39% year-on-year
The company's return on assets has surged by 53% QoQ and by 28% YoY
FTRE's return on equity is up by 48% since the previous quarter but it is down by 30% year-on-year

Dividends

What is FTRE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FTRE.

Financial health

How did Fortrea Holdings financials performed over time
The total assets is 24% greater than the total liabilities
The total assets has declined by 14% year-on-year
Fortrea Holdings's total liabilities has decreased by 4.6% YoY
The debt is 113% greater than the equity
Fortrea Holdings's debt to equity has increased by 42% YoY and by 8% from the previous quarter
FTRE's equity is down by 39% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.